T.P.1.01 Use of the 6min walk test as an endpoint in clinical trials for neuromuscular diseases

1 Washington University School of Medicine, Department of Neurology, St. Louis, United States

2 Erasmus Medical Center, Sophia, Rotterdam, The Netherlands

3 University of Pittsburgh, Department of Neurology, Pittsburgh, United States

4 Children’s National Medical Center, Washington, DC, United States

5 Institut de Myologie, Groupe Hospitalier Pitie-Salpetriere, Paris, France

6 Tower Hematology Oncology, Beverly Hills, United States

7 Mount Sinai School of Medicine, New York, United States

8 Genzyme Corporation, Cambridge, United States